Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias

1. Front Matter

   Pages I-XIII

   PDF

2. Immunologic approaches to the classification of lymphomas and lymphoid leukemias

   • Kenneth A. Foon, Robert P. Gale, Robert F. Todd III

   Pages 1-30

3. Immunologic approaches to the classification of non-Hodgkin’s lymphomas

   • Thomas M. Grogan, Catherine M. Spier, Lynne C. Richter, Catherine S. Rangel

   Pages 31-148

4. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin’s lymphoma by immunological marker analysis of cerebrospinal fluid cells

   • Herbert Hooijkaas, Henk J. Adriaansen, Jacques J. M. van Dongen

   Pages 149-171

5. Detection of residual disease in acute leukemia using immunological markers

   • Daniel H. Ryan, Jacques J. M. van Dongen

   Pages 173-207

6. Radioimmunoscintigraphy of lymphoma with monoclonal antibodies

   • Jorge A. Carrasquillo, Steven M. Larson

   Pages 209-222

7. Radiolabeled Antibodies in Hodgkin’s Disease

   • Stanley E. Order

   Pages 223-229

8. Interferon therapy for lymphoproliferative disorders

   • Mark S. Roth, Paul A. Bunn, Kenneth A. Foon

   Pages 231-252

9. Monoclonal antibody therapy of lymphomas and leukemia

   • Mark S. Kaminski, Kenneth A. Foon

   Pages 253-263

10. Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement

    • Arnold S. Freedman, Tak Takvorian, Lee M. Nadler, Kenneth C. Anderson, Stephen E. Sallan, Jerome Ritz

    Pages 265-283

11. Back Matter

    Pages 285-290

    PDF

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general on­ cology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Un­ fortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.

• Staging
• cancer treatment
• classification
• interferon
• leukemia
• lymphoma
• transplantation
• tumor

• University of Rochester Cancer Center, Rochester, USA

  John M. Bennett

• Department of Internal Medicine, University of Michigan, Ann Arbor, USA

  Kenneth A. Foon

Policies and ethics